S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%
A daily business newspaper · Founded in 2026

Money Talk

Finance and markets: business, quotes, gold, energy and releases.

Enovis Shares Jump 12% as Company Returns to Profit

Enovis shares climbed 12% to $27.44 at midday Thursday after the medical-technology company reported a third-quarter profit, higher sales and stronger adjusted earnings than analysts expected. The results led the company to raise its adjusted earnings forecast for the year.

Enovis Shares Jump 12% as Company Returns to Profit

Enovis reported net income of $3.1 million, or 6 cents a share, compared with a loss of $571.1 million, or $9.99 a share, in the year-earlier quarter. That period included a large goodwill impairment charge. Excluding certain one-time items, earnings were 88 cents a share, above the 77 cents analysts polled by FactSet had forecast.

Net sales rose 1.8% to $558.7 million, also exceeding the $557.1 million expected by Wall Street. The shares were up roughly 3% year-to-date before Thursday’s move.

Chief Executive Damien McDonald said the quarter reflected continued progress on the company’s innovation-led strategy despite a volatile market and cost inflation. “Despite these challenges, we are investing in the technologies that will define the next phase of our growth,” he said.

Enovis now expects full-year revenue of $2.32 billion to $2.35 billion, narrowing its previous range of $2.31 billion to $2.37 billion. It raised its adjusted earnings forecast to $3.58 to $3.79 a share, from a prior range of $3.52 to $3.73 a share.

Share article
TelegramXFacebook

When reusing this material a link to Money Talk is required.

Comments (0)

Leave a comment

No comments yet. Be the first!